azides has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Frenkel, E; Guo, Y; Hsieh, JT; Karam, JA; Stanfield, J; Sun, X | 1 |
| Hashimoto, Y; Masuko, T; Ueno, H | 1 |
2 other study(ies) available for azides and Bladder Cancer
| Article | Year |
|---|---|
Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azides; Blotting, Western; Cell Cycle; Cell Proliferation; Cinnamates; Depsipeptides; Enzyme Inhibitors; Histone Deacetylases; Humans; Mice; Mice, Nude; ortho-Aminobenzoates; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Efficient immunostaining of tissue sections with chemically modified monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Azides; Biomarkers, Tumor; Chromatography, Gel; ErbB Receptors; Flow Cytometry; Humans; Immunoenzyme Techniques; Mice; Nuclear Proteins; Paraffin Embedding; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Receptor, ErbB-2; Staining and Labeling; Succinimides; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1993 |